Co-Diagnostics, Inc. Business Finance Contracts & Agreements
26 Contracts & Agreements
- Credit Agreements (7 contracts)
- Investment Agreements (1)
- Note Agreements (6)
- Purchase Agreements (3)
- Shareholders Agreements (1)
- Stock Agreements (3)
- Underwriting Agreements (3)
- Warrant Agreements (2)
- Warrant Agreement between Co-Diagnostics, Inc and VStock Transfer, LLC. Dated December 31, 2021 (IDMO Warrant) (Filed With SEC on March 24, 2022)
- Warrant Agreement between Co-Diagnostics, Inc and VStock Transfer, LLC. Dated December 31, 2021 (ACI Warrant) (Filed With SEC on March 24, 2022)
- Form of Securities Purchase Agreement, dated February 27, 2020 (Filed With SEC on February 27, 2020)
- Form of Securities Purchase Agreement, dated February 10, 2020 (Filed With SEC on February 11, 2020)
- Form of Securities Purchase Agreement, dated January 23, 2020 (Filed With SEC on January 27, 2020)
- Form of Securities Purchase Agreement, dated January 31, 2019, for the Common Stock (Filed With SEC on February 4, 2019)
- Form of Securities Purchase Agreement, dated January 30, 2019, for the Preferred Stock (Filed With SEC on February 4, 2019)
- 9% Promissory Note, dated August 3, 2018, between Co-Diagnostics, Inc. and Robert Salna for $2,000,000 (Filed With SEC on August 9, 2018)
- Underwriting Agreement dated July 12, 2017 (Filed With SEC on July 13, 2017)
- UNDERWRITING AGREEMENT among CO-DIAGNOSTICS, INC. and WALLACHBETH Capital, LLC and NETWORK 1 FINANCIAL SECURITIES, INC., as Representatives of the Several Underwriters (Filed With SEC on June 9, 2017)
- Form Second Amendment to 12% Revolving Line of Credit Promissory Note Due 2017 between Co-Diagnostics, Inc. and Turks and Caicos Limited Company, Pine Valle Investments, LLC,... (Filed With SEC on May 24, 2017)
- Underwriting Agreement (Filed With SEC on May 24, 2017)
- NON-INTEREST BEARING NOTE DUE 2020 (Filed With SEC on April 28, 2017)
- STOCK PURCHASE AGREEMENT (Filed With SEC on April 28, 2017)
- SHAREHOLDERS AGREEMENT (Filed With SEC on April 28, 2017)
- 10% CONVERTIBLE NOTE DUE 2017 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- 8.5% CONVERTIBLE NOTE DUE 2017 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSORY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROIVIISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- REVOLVING LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 28, 2017)
- 12% CONVERTIBLE NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- CO-DIAGNOSTICS, INC. PROSPERITY INVESTMENTS SUBSCRIPTION AGREEMENT (Filed With SEC on April 28, 2017)